ArticleDrug design, development and therapy2017

Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo.

Sheng Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.